Repligen Corporation (RGEN) financial statements (2022 and earlier)

Company profile

Business Address 41 SEYON STREET
WALTHAM, MA 02453
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments60471752819417414272
Cash and cash equivalents60471752819417412254
Short-term investments     2018
Receivables117714436281712
Inventory, net of allowances, customer advances and progress billings184955542392518
Inventory184955542392518
Prepaid expense7531101
Deferred costs   0000
Other current assets8911000
Other undisclosed current assets115112111
Total current assets:932902642276243184103
Noncurrent Assets
Operating lease, right-of-use asset1022526
Property, plant and equipment125674832221514
Long-term investments and receivables      2
Long-term investments      2
Intangible assets, net (including goodwill)1,1989056814624728927
Goodwill8606184683273276014
Intangible assets, net (excluding goodwill)3372872131351453013
Restricted cash and investments     00
Deferred income tax assets2  
Other noncurrent assets11006  
Deferred tax assets, net4   
Other undisclosed noncurrent assets 23    
Total noncurrent assets:1,4271,00175849950110543
TOTAL ASSETS:2,3581,9031,400775744289146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities112704526252119
Accounts payable36171110757
Accrued liabilities75533316181612
Debt2552444103   
Other undisclosed current liabilities85     
Total current liabilities:37531948130252119
Noncurrent Liabilities
Long-term debt and lease obligation10226260 9995 
Long-term debt, excluding current maturities  233 9995 
Operating lease, liability1022627
Liabilities, other than long-term debt9712292845
Deferred tax liabilities, net2525  
Other liabilities3124245
Business combination, contingent consideration, liability94      
Other undisclosed noncurrent liabilities332730    
Total noncurrent liabilities:2335529229127995
Total liabilities:60837434015915212023
Stockholders' equity
Stockholders' equity attributable to parent1,7501,5291,060616592169123
Common stock1110000
Additional paid in capital1,5721,4611,068643629242203
Accumulated other comprehensive income (loss)(17)2(15)(12)(6)(14)(9)
Retained earnings (accumulated deficit)194666(16)(32)(60)(72)
Total stockholders' equity:1,7501,5291,060616592169123
TOTAL LIABILITIES AND EQUITY:2,3581,9031,400775744289146

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues67136627019414110584
Revenue, net14110584
Cost of revenue(285)(157)(119)(87)(67)(50)(39)
Cost of goods and services sold(279)(157)(119)(87)(67)(47)(35)
Gross profit:385210151108745444
Operating expenses(218)(140)(115)(82)(60)(38)(30)
Operating income:167703626141614
Nonoperating expense(14)(11)(10)(5)(0)(1)(0)
Investment income, nonoperating0252000
Other nonoperating income (expense)(1)(0)(0)0(1)(1)(0)
Interest and debt expense(0)(12)(6)(7)(6)(4)(0)
Income from continuing operations before equity method investments, income taxes:15447211571213
Other undisclosed income from continuing operations before income taxes01267   
Income from continuing operations before income taxes:15459262171213
Income tax expense (benefit)(25)1(5)(5)21(0)(4)
Net income available to common stockholders, diluted:12860211728129

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:12860211728129
Other comprehensive loss      (3)
Comprehensive income:12860211728127
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(19)17(3)(6)7(5) 
Comprehensive income, net of tax, attributable to parent:1097718113667

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: